Role of Somatostatin Analogs in the Treatment of Neuroendocrine Tumors

Neuroendocrine tumors are rare epithelial neoplasms with neuroendocrine differentiation that most commonly originate in the lungs and gastrointestinal tract.  Many patients have advanced disease not amenable to surgery or local management. Some tumors also secrete peptides, such as serotonin, that lead to syndromes of hormone excess, such as diarrhea and flushing.  Thus, management of patients with neuroendocrine tumors often requires a dual approach including hormone symptom management and systemic tumor control.  Somatostatin analogues have long been a mainstay of managing the hormone-related symptoms.  There is also increasing evidence for the use of somatostatin analogues for tumor control in patients with well-differentiated neuroendocrine tumors.  This article will review the role of somatostatin analogues in the treatment of NETs.

Target Audience

This activity has been designated to meet the educational needs of physicians and nurses involved in the management of patients with cancer.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Explain some of the clinical approaches available to manage patients with neuroendocrine tumors
  • Summarize the role of somatostatin analogues in the treatment of neuroendocrine tumors
Additional information
Supporters: 

No commercial support was received for this article.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Physician
Course opens: 
01/01/2015
Course expires: 
12/31/2015
Cost:
$0.00

Sujata Narayanan, MD, MS
Stanford University School of Medicine
Stanford, California

Pamela L. Kunz, MD
Stanford University School of Medicine
Stanford, California

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Physician

Accreditation Period

Course opens: 
01/01/2015
Course expires: 
12/31/2015

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for article and certificate viewing/printing